Acme 42 Gmbh agreed to acquire remaining 42.28% stake in InVision Aktiengesellschaft (XTRA:IVX) for ?95 million on December 7, 2023. Under the terms of agreement, Acme 42 Gmbh will be paying cash consideration. Acme 42 GmbH will prepare an Offer Document and submit it to the German Federal Financial Supervisory Authority (?BaFin?) for review and approval prior to publication within the statutory period of 4 weeks after the announcement of the offer. The Delisting Agreement provides that the consideration per InVision Share offered to the shareholders of InVision Shares in the Offer Document shall be the statutory minimum price pursuant to Section 39 para. 3 sentence 2 of the German Stock Exchange Act (?BörsG?) in conjunction with Section 31 para. 1 and 7 of the German Securities Acquisition and Takeover Act (?WpÜG?) in conjunction with Section 5 para. 3 WpÜG Offer Regulation, as notified by BaFin, subject to any increases pursuant to the provisions of the WpÜG (including any increases pursuant to Section 31 para. 2 to 6 WpÜG). The Offer will be made exclusively under the laws of the Federal Republic of Germany, especially under the WpÜG, the BörsG and certain provisions of the securities laws of the United States of America applicable to cross-border tender offers. As a part of acquisition, Acme 42 reserves the right, to the extent legally permitted, to directly or indirectly acquire further shares in InVision outside the Offer on or off the stock exchange.

The offer will not be subject to any closing conditions. Considering the overall circumstances, the Management Board and Supervisory Board are of the opinion that the conclusion of the Delisting Agreement and the delisting are in the interest of the Company and have approved the Delisting Agreement.